Lingo is priced at $49 for one 14-day sensor, $89 for two sensors, or $249 for six sensors, matching Dexcom’s monthly price for its Stelo over-the-counter continuous glucose monitor (CGM). Abbott and ...

Time spent above, not below, the target glucose range was associated with mortality in a study of adults with type 2 diabetes ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

To date, CGM use in India is not widespread ... potential excess inventory levels and inventory imbalances at the company’s distributors, losses or system failures with respect to Trinity Biotech’s ...

Eversense 365 is said to be the world's first one-year CGM system, offering a new long-term solution for diabetes management.

Their research has been published in Science Advances, titled "Coin-sized, fully integrated, and minimally invasive ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...

The FDA has cleared Senseonics and Ascensia Diabetes Care's Eversense 365 Glucose Monitoring System. This system is designed for Type 1 and Type 2 diabetics 18 and older and will be the first ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

A Maryland-based healthcare company is turning heads so far during Tuesday’s session after the it was announced that the ...